SMJ articles in the category "Osteoporosis"

Original Article

Evaluation of Top-Ranked Search Engine Web-Based Osteoporosis Materials

Objective: The purpose of this study was to examine the health literacy and quality of information on online Web sites about osteoporosis using the suitability assessment of materials (SAM) method. Methods: The search terms “osteoporosis” and “weak bones” were entered separately into three different search engines: Google, Bing, and Yahoo….

Posted in: health information 2 Osteoporosis 29

Review Article

CME Article: Osteoporosis in Adult Patients with Intellectual and Developmental Disabilities: Special Considerations for Diagnosis, Prevention, and Management

 As medical care progresses, patients with intellectual and developmental disabilities are living longer and beginning to experience diseases that commonly afflict the aging population, such as osteoporosis. Osteoporosis and resultant fractures increase disability and threaten the independence of this vulnerable population. In addition, the diagnosis, prevention, and management of osteoporosis…

Posted in: cerebral palsy 6 Down syndrome 3 intellectual and developmental disabilities 3 Osteoporosis 29

Original Article

Weight-Bearing Physical Activity Influences the Effect of Vitamin D on Bone Turnover Markers in Patients with Intellectual Disability

Objectives: Individuals with intellectual disabilities (IDs) are at increased risk for low bone mass and fragility fractures, and those who are nonambulatory may be at even higher risk. Patients with IDs often are vitamin D deficient, but there is little information concerning how vitamin D treatment of patients with IDs…

Posted in: fracture 7 osteomalacia 3 Osteoporosis 29 vitamin D 17

Original Article

Prevalence of Osteopenia and Osteoporosis in Patients with Noncystic Fibrosis Bronchiectasis

Objective: The objective of our study was to define the prevalence of osteoporosis and osteopenia in patients with noncystic fibrosis bronchiectasis (NCFB). Methods: We conducted a retrospective chart review of all patients with physician-diagnosed NCFB evaluated at Mayo Clinic Florida between January 1, 2011 and June 3, 2013. Results: A…

Posted in: osteopenia 5 Osteoporosis 29

Original Article

Osteoporosis in Postmenopausal Women: Considerations in Prevention and Treatment (Women's Health Series)

Osteoporosis, the most common human bone disease, affects 8 million American women and has significant morbidity and mortality. Screening is important in older women and younger postmenopausal women with additional risk factors for osteoporosis/fracture. Preventive measures include avoiding smoking, excessive alcohol/caffeine intake, and falls in addition to maintaining adequate calcium/vitamin…

Posted in: menopause 2 Osteoporosis 29 Prevention 18 screening 33 Treatment 22

Original Article

Prevalence and Significance of Decreased Bone Density in Pulmonary Arterial Hypertension

Objective: Decreased bone mineral density has been found in the advanced stages of various lung diseases. Limited data are available about prevalence and risk factors for osteoporosis/osteopenia (OP) in pulmonary arterial hypertension (PAH). Methods: Patients with PAH (either idiopathic or secondary to scleroderma [SSC-PAH]) who underwent bone density testing for…

Posted in: Osteoporosis 29 pulmonary arterial hypertension 5 scleroderma 2

Review

Osteoporosis in Adults with Intellectual Disabilities

The medical care of adults with intellectual disabilities (ID) originates in primary care physicians’ offices. With the move toward the deinstitutionalization of these individuals in the 1970s and 1980s and the increasing longevity of this population, more adults with disabilities are living in the community. Primary care providers need to…

Posted in: bone mineral density 6 developmental disabilities 2 intellectual disabilities 2 Osteoporosis 29

Original Article

Knowledge of Osteoporosis Among Men in the Primary Care Setting

Objectives: Osteoporosis has been often viewed as a disease affecting women; however, men are at risk for osteoporosis, and the mortality after hip fracture in men older than 75 years of age is significantly higher than in women. We aimed to assess knowledge of osteoporosis and its risk factors in…

Posted in: knowledge 6 men 2 Osteoporosis 29

Original Article

Osteoporosis Treatment Following Hip Fracture: How Rates Vary by Service

Objectives: Osteoporosis is a prevalent condition among older people. It is often undiagnosed until patients suffer fragility fractures. Previous studies have shown low rates of initiating osteoporosis treatment during the acute hip fracture hospitalization. It is not clear if this varies by the treating service. We compared the rates of…

Posted in: adherence 10 Guidelines 10 hip fracture 5 Osteoporosis 29 rehabilitation 2

Expired CME Article

Algorithm for the Management of Osteoporosis

Osteoporosis is a common skeletal disease that weakens bones and increases the risk of fractures. It affects about one half of women over the age of 60, and one third of older men. With appropriate care, osteoporosis can be prevented; and when present, it can be easily diagnosed and managed….

Posted in: FRAX 2 osteopenia 5 Osteoporosis 29 vitamin D 17

Original Article

Improved GI Tolerability with Monthly Ibandronate in Women Previously Using Weekly Bisphosphonates

Objective:This subanalysis of CURRENT, an open-label, 6-month, multicenter study, assesses changes in gastrointestinal (GI) tolerability with once-monthly oral ibandronate in women who switched from once-weekly bisphosphonates and had reported GI symptoms with their previous weekly bisphosphonate regimen.Methods:Postmenopausal women currently taking a weekly bisphosphonate switched to 150 mg monthly ibandronate. At…

Posted in: bisphosphonates 5 Osteoporosis 29

Review Article

Management of Osteoporosis Among Home Health and Long-Term Care Patients with a Prior Fracture

Key PointsDiagnosis and treatment of osteoporosis and fractures among nursing home and home health care patients is commonly overlooked.Treatment with calcium and vitamin D has been associated with decreased fall and fracture risk. However, those with a history of fracture or osteoporosis should also be treated with prescription osteoporosis therapy.Among…

Posted in: bisphosphonate 4 fracture 7 long-term care 2 Osteoporosis 29

Review Article

New Guidelines for the Prevention and Treatment of Osteoporosis

Abstract:The World Health Organization Fracture Risk Assessment Tool (FRAX™) and the National Osteoporosis Foundation’s (NOF) Clinician’s Guide to Prevention and Treatment of Osteoporosis are helpful clinical tools in the management of osteoporosis. Appropriate use of these tools requires a clear understanding of their limitations as well as their benefits. Good…

Posted in: FRAX 2 Guidelines 10 Osteoporosis 29 Treatment 22

Review Article

Maximizing Effectiveness of Bisphosphonate Therapy for Osteoporosis

While highly prevalent, osteoporosis is greatly underdiagnosed and undertreated in clinical practice. Even when appropriate treatments are prescribed, patient adherence to bisphosphonate therapy is low. As osteoporosis is a silent disease, and therapy is required for many months before benefit is realized, strategies to increase bone mineral density (BMD) and…

Posted in: adherence 10 bisphosphonate 4 Osteoporosis 29

Review Article

Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions

The International Society for Clinical Densitometry (ISCD) periodically holds Position Development Conferences (PDCs) for the purpose of establishing standards and guidelines for the assessment of skeletal health—the nomenclature, indications, acquisition, analysis, quality control, interpretation, and reporting of bone density tests. Topics are selected for consideration according to criteria that include…

Posted in: DXA 2 Guidelines 10 ISCD 2 Osteoporosis 29

Review Article

Special Report on the 2007 Pediatric Position Development Conference of the International Society for Clinical Densitometry

The International Society for Clinical Densitometry periodically holds Position Development Conferences (PDCs) for the purpose of establishing standards and guidelines for the assessment of skeletal health, including nomenclature, indications, acquisition, analysis, quality control, interpretation, and reporting of bone density tests. Topics are selected for consideration according to criteria that include…

Posted in: DXA 2 Guidelines 10 ISCD 2 Osteoporosis 29 pediatrics 33

Expired CME Article

Osteonecrosis of the Jaw

The first bisphosphonate (etidronate) was approved by the FDA in 1977; alendronate was approved in 1995 for the prevention and treatment of osteoporosis. Bisphosphonates have emerged as the agents of choice for the treatment of osteoporosis and have proved useful in the treatment of skeletal complications of malignancy (hypercalcemia, bone…

Posted in: bisphosphonate 4 osteonecrosis 4 Osteoporosis 29

Review Article

Reduced Fracture Rates Observed Only in Patients With Proper Persistence and Compliance With Bisphosphonate Therapies

Numerous studies have analyzed data from administrative claims databases to determine persistence and compliance with bisphosphonate therapy for osteoporosis; several of these studies have also examined how persistence and compliance with therapy affect fracture outcomes. All of the studies included in this review demonstrated that patients who were persistent or…

Posted in: bisphosphonates 5 Osteoporosis 29 persistence 3

Original Article

Osteoporosis Preventive Care in White and Black Women in Community Family Medicine Settings

Background: Osteoporosis has been studied predominantly in white postmenopausal women. Materials and Methods: We performed a cross-sectional survey of a random sample of 400 women aged 45 years and older enrolled in a family medicine community-based research network. Participants responded to 42 items regarding osteoporosis screening and prevention during primary…

Posted in: disparities 16 health services research 10 Osteoporosis 29 Women's Health 19

Original Article

Adherence and Persistence Associated with the Pharmacologic Treatment of Osteoporosis in a Managed Care Setting

Background: The effectiveness of chronic therapies can be compromised by poor adherence and persistence. Materials and Methods: Investigators identified a continuously benefit-eligible cohort of women from a large, geographically diverse, national managed care plan who were newly diagnosed and treated for osteoporosis with alendronate, risedronate, or raloxifene. Drug utilization parameters…

Posted in: adherence 10 bisphosphonates 5 Osteoporosis 29 persistence 3 raloxifene 2
SMA Menu